Aldosterone Secretion in Patients With Primary Hyperparathyroidism Without Arterial Hypertension

Endocr Pract. 2021 Nov;27(11):1072-1076. doi: 10.1016/j.eprac.2021.04.886. Epub 2021 Jun 21.

Abstract

Objective: There is a direct bidirectional link between parathyroid hormone (PTH) and the renin-angiotensin-aldosterone system (RAAS), but few studies evaluated the RAAS in patients with primary hyperparathyroidism (PHPT), mainly biased from concomitant antihypertensive treatment.

Methods: We retrospectively evaluated a consecutive series of 130 normotensive patients with PHPT comparing aldosterone (ALD) levels and plasma renin activity (PRA) with the demographic, biochemical, or clinical features of PHPT.

Results: No correlation was found between ALD and PRA, and the demographic, biochemical, and bone densitometry parameters in patients with PHPT without hypertension, with the exception of a negative correlation between age and serum PRA. Moreover, there was no significant correlation between PTH and ALD levels even in patients whose PTH level was >100 ng/L (P = .088).

Conclusion: In our normotensive patients with PHPT, the ALD, PRA, and aldosterone/renin ratio were not correlated to PTH and calcium levels. In addition, they were neither related to PHPT clinical presentation nor renal function, vitamin D status, bone mass loss, or the presence of comorbidities such as diabetes and obesity. Further studies are needed to clarify the complex interplay between PTH and the RAAS in the modern PHPT presentation.

Keywords: RAAS; arterial hypertension; primary aldosteronism; primary hyperparathyroidism.

MeSH terms

  • Aldosterone
  • Humans
  • Hyperparathyroidism, Primary* / complications
  • Hypertension* / epidemiology
  • Renin-Angiotensin System
  • Retrospective Studies

Substances

  • Aldosterone